Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.

Thrombosis research - 15 Feb 2003

Ramacciotti Eduardo, Wolosker Nelson, Puech-Leao Pedro, Zeratti Eduardo Antônio, Gusson Paula Regina, del Giglio Auro, Franco Rendrik F

Abstract excerpt

Venous thromboembolism (VTE) is a common complication in patients with malignant disease. In addition to well-established acquired risk factors for VTE, several genetic risk factors, mainly related to the haemostatic system, are known to influence thrombotic risk. However, the contribution of gene abnormalities to thrombotic tendency in cancer patients remains poorly explored. We performed a prospective study to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Factor XIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Odds Ratio

Share to Point Mutation

Share to Prevalence

Share to Prothrombin

Share to Venous Thrombosis

Source

Identifiers

PMID: 12757770
DOI: 10.1016/s0049-3848(03)00179-8

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.PMID 12757770Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Prothrombotic genotypes and risk of venous thromboembolism in cancer.Semantic proximity Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.Semantic proximity Read ↗

No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.Semantic proximity Read ↗

Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.Semantic proximity Read ↗

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.